392 related articles for article (PubMed ID: 17329437)
1. Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis.
Benito C; Romero JP; Tolón RM; Clemente D; Docagne F; Hillard CJ; Guaza C; Romero J
J Neurosci; 2007 Feb; 27(9):2396-402. PubMed ID: 17329437
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoid receptor and N-acyl phosphatidylethanolamine phospholipase D--evidence for altered expression in multiple sclerosis.
Zhang H; Hilton DA; Hanemann CO; Zajicek J
Brain Pathol; 2011 Sep; 21(5):544-57. PubMed ID: 21251115
[TBL] [Abstract][Full Text] [Related]
3. Presence and regulation of cannabinoid receptors in human retinal pigment epithelial cells.
Wei Y; Wang X; Wang L
Mol Vis; 2009 Jun; 15():1243-51. PubMed ID: 19547718
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of fatty acid amide hydrolase exacerbates experimental fibrosis by enhanced endocannabinoid-mediated activation of CB1.
Palumbo-Zerr K; Horn A; Distler A; Zerr P; Dees C; Beyer C; Selvi E; Cravatt BF; Distler O; Schett G; Distler JH
Ann Rheum Dis; 2012 Dec; 71(12):2051-4. PubMed ID: 22915616
[TBL] [Abstract][Full Text] [Related]
5. Glial expression of cannabinoid CB(2) receptors and fatty acid amide hydrolase are beta amyloid-linked events in Down's syndrome.
Núñez E; Benito C; Tolón RM; Hillard CJ; Griffin WS; Romero J
Neuroscience; 2008 Jan; 151(1):104-10. PubMed ID: 18068305
[TBL] [Abstract][Full Text] [Related]
6. Effects of pro-inflammatory cytokines on cannabinoid CB1 and CB2 receptors in immune cells.
Jean-Gilles L; Braitch M; Latif ML; Aram J; Fahey AJ; Edwards LJ; Robins RA; Tanasescu R; Tighe PJ; Gran B; Showe LC; Alexander SP; Chapman V; Kendall DA; Constantinescu CS
Acta Physiol (Oxf); 2015 May; 214(1):63-74. PubMed ID: 25704169
[TBL] [Abstract][Full Text] [Related]
7. [Membrane cholesterol mediates the endocannabinoids-anandamide affection on HepG2 cells].
Wu WJ; Yang Q; Cao QF; Zhang YW; Xia YJ; Hu XW; Tang WX
Zhonghua Gan Zang Bing Za Zhi; 2010 Mar; 18(3):204-8. PubMed ID: 20380798
[TBL] [Abstract][Full Text] [Related]
8. Anti-Inflammatory Effects of Fatty Acid Amide Hydrolase Inhibition in Monocytes/Macrophages from Alzheimer's Disease Patients.
Chiurchiù V; Scipioni L; Arosio B; Mari D; Oddi S; Maccarrone M
Biomolecules; 2021 Mar; 11(4):. PubMed ID: 33810505
[TBL] [Abstract][Full Text] [Related]
9. Spinal neuronal cannabinoid receptors mediate urodynamic effects of systemic fatty acid amide hydrolase (FAAH) inhibition in rats.
Füllhase C; Schreiber A; Giese A; Schmidt M; Montorsi F; Gratzke C; La Croce G; Castiglione F; Stief C; Hedlund P
Neurourol Urodyn; 2016 Apr; 35(4):464-70. PubMed ID: 25788026
[TBL] [Abstract][Full Text] [Related]
10. COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord.
Yiangou Y; Facer P; Durrenberger P; Chessell IP; Naylor A; Bountra C; Banati RR; Anand P
BMC Neurol; 2006 Mar; 6():12. PubMed ID: 16512913
[TBL] [Abstract][Full Text] [Related]
11. Increased placental expression of cannabinoid receptor 1 in preeclampsia: an observational study.
Fügedi G; Molnár M; Rigó J; Schönléber J; Kovalszky I; Molvarec A
BMC Pregnancy Childbirth; 2014 Dec; 14():395. PubMed ID: 25444073
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic potential of a novel cannabinoid agent CB52 in the mouse model of experimental autoimmune encephalomyelitis.
Ribeiro R; Yu F; Wen J; Vana A; Zhang Y
Neuroscience; 2013 Dec; 254():427-42. PubMed ID: 24036373
[TBL] [Abstract][Full Text] [Related]
13. Regulation of cannabinoid receptor gene expression and endocannabinoid levels in lymphocyte subsets by interferon-β: a longitudinal study in multiple sclerosis patients.
Sánchez López AJ; Román-Vega L; Ramil Tojeiro E; Giuffrida A; García-Merino A
Clin Exp Immunol; 2015 Jan; 179(1):119-27. PubMed ID: 25169051
[TBL] [Abstract][Full Text] [Related]
14. Dynamics of expression and localization of the cannabinoid system in granulosa cells during oocyte nuclear maturation.
Agirregoitia E; Ibarra-Lecue I; Totorikaguena L; Mendoza R; Expósito A; Matorras R; Urigüen L; Agirregoitia N
Fertil Steril; 2015 Sep; 104(3):753-60. PubMed ID: 26144572
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains.
Benito C; Núñez E; Tolón RM; Carrier EJ; Rábano A; Hillard CJ; Romero J
J Neurosci; 2003 Dec; 23(35):11136-41. PubMed ID: 14657172
[TBL] [Abstract][Full Text] [Related]
16. Expression of the endocannabinoid system in human first trimester placenta and its role in trophoblast proliferation.
Habayeb OM; Taylor AH; Bell SC; Taylor DJ; Konje JC
Endocrinology; 2008 Oct; 149(10):5052-60. PubMed ID: 18599552
[TBL] [Abstract][Full Text] [Related]
17. Temporal and spatial distribution of the cannabinoid receptors (CB1, CB2) and fatty acid amide hydroxylase in the rat ovary.
Bagavandoss P; Grimshaw S
Anat Rec (Hoboken); 2010 Aug; 293(8):1425-32. PubMed ID: 20665820
[TBL] [Abstract][Full Text] [Related]
18. β-Amyloid exacerbates inflammation in astrocytes lacking fatty acid amide hydrolase through a mechanism involving PPAR-α, PPAR-γ and TRPV1, but not CB₁ or CB₂ receptors.
Benito C; Tolón RM; Castillo AI; Ruiz-Valdepeñas L; Martínez-Orgado JA; Fernández-Sánchez FJ; Vázquez C; Cravatt BF; Romero J
Br J Pharmacol; 2012 Jun; 166(4):1474-89. PubMed ID: 22321194
[TBL] [Abstract][Full Text] [Related]
19. Activation of CB2 receptor is required for the therapeutic effect of ABHD6 inhibition in experimental autoimmune encephalomyelitis.
Wen J; Ribeiro R; Tanaka M; Zhang Y
Neuropharmacology; 2015 Dec; 99():196-209. PubMed ID: 26189763
[TBL] [Abstract][Full Text] [Related]
20. Identification of the CB1 cannabinoid receptor and fatty acid amide hydrolase (FAAH) in the human placenta.
Park B; Gibbons HM; Mitchell MD; Glassa M
Placenta; 2003 May; 24(5):473-8. PubMed ID: 12744923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
